Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 475 of 808 entries
View as:

Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03289039 Org: User:
Start: 10/25/17 End: 07/20/21 Due: 07/20/22

Personal Patient Profile Prostate (P4) Randomized, Multisite Trial

Phase: N/A Priority: Normal
NCT ID: NCT00692653 Org: User:
Start: 02/28/07 End: 12/31/09 Due: 12/31/10

A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT03899805 Org: User:
Start: 05/13/19 End: 07/16/25 Due: 07/16/26

SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01574274 Org: User:
Start: 06/30/12 End: 07/01/27 Due: 07/01/28

Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate

Phase: N/A Priority: Normal
NCT ID: NCT00165516 Org: User:
Start: 01/31/04 End: 12/31/09 Due: 12/31/10

Dasatinib in Advanced Squamous Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01491633 Org: User:
Start: 09/30/11 End: 05/31/13 Due: 05/31/14

Capecitabine in Women With Operable Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00148720 Org: User:
Start: 09/30/04 End: - Due: -

Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds

Phase: N/A Priority: Normal
NCT ID: NCT03447886 Org: User:
Start: 03/09/18 End: 08/27/18 Due: 08/27/19

Healthy Living After Cancer: Weight Management Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT01978899 Org: User:
Start: 11/30/13 End: 02/29/16 Due: 02/28/17

Survivor-Sleep Health Information Program

Phase: N/A Priority: Normal
NCT ID: NCT04863157 Org: User:
Start: 05/24/21 End: 12/31/22 Due: 12/31/23

The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02653755 Org: User:
Start: 05/31/16 End: 06/30/26 Due: 06/30/27

Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02698891 Org: User:
Start: 04/07/16 End: 11/30/21 Due: 11/30/22

OPTimizing Treatment Focused Genetic Testing IN Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04066361 Org: User:
Start: 12/19/19 End: 11/30/22 Due: 11/30/23

EHR-embedded OCDT in Breast or GI Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03858712 Org: User:
Start: 03/13/19 End: 11/23/21 Due: 11/23/22

Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches

Phase: N/A Priority: Normal
NCT ID: NCT01740219 Org: User:
Start: 09/30/11 End: 09/30/13 Due: 09/30/14

Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00910000 Org: User:
Start: 06/30/09 End: 10/31/15 Due: 10/31/16

Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLL

Phase: N/A Priority: Normal
NCT ID: NCT00330252 Org: User:
Start: 05/31/06 End: 01/31/14 Due: 01/31/15

FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01747551 Org: User:
Start: 01/31/13 End: 07/26/17 Due: 07/26/18

Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00355407 Org: User:
Start: 06/30/06 End: 08/31/07 Due: 08/31/08

Sildenafil Citrate in Waldenstrom's Macroglobulinemia

Phase: N/A Priority: Normal
NCT ID: NCT00165295 Org: User:
Start: 09/30/05 End: 06/30/07 Due: 06/30/08

Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003045 Org: User:
Start: 04/30/97 End: 12/31/03 Due: 12/31/04

C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT00402545 Org: User:
Start: 01/31/07 End: 07/31/09 Due: 07/31/10

A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)

Phase: N/A Priority: Normal
NCT ID: NCT02502695 Org: User:
Start: 06/30/15 End: 05/31/19 Due: 05/31/20

GROW (Glioma Specialists Reaching Out With Support) Support

Phase: N/A Priority: Normal
NCT ID: NCT05233215 Org: User:
Start: 07/31/22 End: 06/15/24 Due: 06/15/25

Improving Communication Between Cancer Patients & Oncologists

Phase: N/A Priority: Normal
NCT ID: NCT02969031 Org: User:
Start: 02/14/17 End: 08/31/18 Due: 08/31/19